GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.500 $0.720 Thursday, 18th Apr 2024 ADXS stock ended at $0.570. This is 11.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 14.20% from a day low at $0.500 to a day high of $0.571.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2021-03-19 $0.84 $0.86 $0.81 $0.84 3 274 268
2021-03-18 $0.87 $0.89 $0.82 $0.84 4 562 102
2021-03-17 $0.83 $0.89 $0.82 $0.87 4 415 463
2021-03-16 $0.95 $0.95 $0.81 $0.84 7 842 624
2021-03-15 $0.94 $0.96 $0.90 $0.92 7 862 074
2021-03-12 $0.82 $0.93 $0.80 $0.87 7 832 428
2021-03-11 $0.81 $0.84 $0.793 $0.82 4 665 963
2021-03-10 $0.85 $0.85 $0.762 $0.80 7 295 754
2021-03-09 $0.700 $0.87 $0.692 $0.84 10 992 536
2021-03-08 $0.710 $0.719 $0.660 $0.669 5 331 469
2021-03-05 $0.730 $0.759 $0.575 $0.680 11 230 406
2021-03-04 $0.710 $0.740 $0.625 $0.705 14 253 630
2021-03-03 $0.83 $0.84 $0.745 $0.767 8 879 973
2021-03-02 $0.88 $0.89 $0.82 $0.83 4 364 240
2021-03-01 $0.89 $0.92 $0.87 $0.88 4 548 641
2021-02-26 $0.88 $0.91 $0.82 $0.84 5 823 850
2021-02-25 $1.01 $1.01 $0.87 $0.88 8 722 986
2021-02-24 $0.91 $1.06 $0.91 $1.01 10 691 054
2021-02-23 $0.96 $0.99 $0.690 $0.88 18 544 434
2021-02-22 $1.18 $1.18 $1.07 $1.07 9 984 728
2021-02-19 $1.23 $1.25 $1.14 $1.17 8 750 092
2021-02-18 $1.33 $1.33 $1.13 $1.20 17 223 097
2021-02-17 $1.13 $1.57 $1.09 $1.41 51 261 940
2021-02-16 $1.17 $1.17 $1.07 $1.13 10 103 054
2021-02-12 $1.12 $1.13 $1.04 $1.08 8 752 611
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT